fda glp-1 compounding enforcement september 2025 news october 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns FDA – Partnership for Safe Medicines Beyond the Headlines: FDA Warning

However, the impact on fibrosis improvement was less consistent, with no significant differences observed between semaglutide and placebo in some trials

Statements Author contributions DK and YT wrote and revised the manuscript

I don't have that problem anymore

The formula is a clearly identified once-daily capsule built around chicory root inulin, potato resistant starch, and a named three-species probiotic blend - disclosed specifically enough that you can actually check it against the published research yourself, which gives you a more specific basis for comparison than a label that discloses only a proprietary-blend name

The technical framework relies on the NCPDP SCRIPT version 2017071 standard (and its successors)